ARE ELDERLY PATIENTS POOR CANDIDATES FOR PEGYLATED INTERFERON PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C?
- 8 March 2006
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 54 (3), 549-550
- https://doi.org/10.1111/j.1532-5415.2006.00643_4.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survivalScandinavian Journal of Gastroenterology, 2005
- Prevention of Hepatocellular CarcinomaClinics in Liver Disease, 2005
- 549 Hepatitis C in 2,410 patients 65 years or older. A severe and neglected curable disease?Hepatology, 2003
- Treatment of Hepatitis C Virus in Elderly Persons With InterferonThe Journals of Gerontology: Series A, 1995
- Interferon therapy for patients more than 60 years of age with chronic hepatitis CJournal of Gastroenterology and Hepatology, 1995
- The Use of Recombinant Interferon Alfa‐2b in Elderly Patients with Anti‐HCV‐Positive Chronic Active HepatitisJournal of the American Geriatrics Society, 1993